Alsheikhly A R, Wåhlin B, Andersson T, Perlmann P
J Immunol. 1984 Jun;132(6):2760-6.
The effect of Parotis virus on antibody-dependent cellular cytotoxicity in vitro (ADCC) of human lymphocytes was investigated in a 51Cr-release assay and, at the effector cell level, in an ADCC plaque assay. Target cells were bovine or chicken erythrocytes, which are not susceptible to natural cytotoxicity (NK) of human lymphocytes. They were not killed when incubated with virus-treated lymphocytes in the absence of antibodies. Treatment of the lymphocytes or the target cells with small amounts of virus, however, resulted in a very significant enhancement of ADCC. The same results were obtained with live or UV-inactivated virus, suggesting that enhancement was a passive phenomenon not requiring infection. Enhancement was already significant after 3 hr of incubation, indicating that it was independent of endogenously released interferon. Enhancement of ADCC by virus was due to effector cell recruitment rather than due to the increase of the cytotoxic potential of the individual K cell. The highest frequency of effector cells was present in Percoll fractions enriched in large granular lymphocytes (LGL). Virus treatment resulted in recruitment of effector cells carrying T cell markers such as the T3 antigen (OKT3+), receptors for sheep erythrocytes, or Fc receptors for IgM. In contrast, the absolute number of K cells carrying the HNK-1 marker (Leu-7) or receptors for C3 fragments was not changed by the virus. It is concluded that Parotis virus enhances ADCC by improving effector cell-target cell contacts, resulting in recruitment of effector cells with T cell characteristics. Recruitment is accompanied by a significant reduction of the antibody concentration needed for ADCC induction. This virus-mediated enhancement of ADCC may be of importance for protection of the host in the early phases of a virus infection in which the amounts of anti-viral IgG antibodies capable of inducing cellular cytotoxicity may yet be very small.
在51Cr释放试验中研究了腮腺病毒对人淋巴细胞体外抗体依赖性细胞毒性(ADCC)的影响,并在效应细胞水平上通过ADCC空斑试验进行了研究。靶细胞是牛或鸡的红细胞,它们对人淋巴细胞的天然细胞毒性(NK)不敏感。在没有抗体的情况下,当它们与经病毒处理的淋巴细胞一起孵育时不会被杀死。然而,用少量病毒处理淋巴细胞或靶细胞会导致ADCC显著增强。用活病毒或紫外线灭活病毒都得到了相同的结果,这表明增强是一种被动现象,不需要感染。孵育3小时后增强就已经很显著,这表明它与内源性释放的干扰素无关。病毒对ADCC的增强是由于效应细胞的募集,而不是由于单个K细胞细胞毒性潜力的增加。效应细胞的最高频率出现在富含大颗粒淋巴细胞(LGL)的Percoll组分中。病毒处理导致携带T细胞标志物(如T3抗原(OKT3 +)、绵羊红细胞受体或IgM的Fc受体)的效应细胞的募集。相反,携带HNK - 1标志物(Leu - 7)或C3片段受体的K细胞的绝对数量没有因病毒而改变。结论是腮腺病毒通过改善效应细胞与靶细胞的接触来增强ADCC,从而导致具有T细胞特征的效应细胞的募集。募集伴随着诱导ADCC所需抗体浓度的显著降低。这种病毒介导的ADCC增强在病毒感染的早期阶段对宿主的保护可能很重要,在这个阶段能够诱导细胞毒性的抗病毒IgG抗体的量可能还非常少。